MedPath

Huabo Biopharm Co., Ltd.

Huabo Biopharm Co., Ltd. logo
🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

A Study of Injection HB0017 in Adult Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Subjects
Interventions
Drug: placebo
First Posted Date
2020-08-07
Last Posted Date
2021-07-28
Lead Sponsor
Huabo Biopharm Co., Ltd.
Target Recruit Count
40
Registration Number
NCT04505033
Locations
🇳🇿

Auckland Clinical Studies Ltd, Grafton, Auckland, New Zealand

A Study of Injection HB002.1T in Subjects With Solid Tumor

Phase 1
Completed
Conditions
Solid Tumor
Interventions
First Posted Date
2018-08-17
Last Posted Date
2021-07-28
Lead Sponsor
Huabo Biopharm Co., Ltd.
Target Recruit Count
27
Registration Number
NCT03636750
Locations
🇨🇳

Shanghai East Hospital, Shanghai, Shanghai, China

A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Phase 1
Completed
Conditions
Neovascular Age-Related Macular Degeneration
Interventions
First Posted Date
2018-01-02
Last Posted Date
2020-07-29
Lead Sponsor
Huabo Biopharm Co., Ltd.
Target Recruit Count
21
Registration Number
NCT03387566
Locations
🇨🇳

Shanghai General Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath